Acuity Pharmaceuticals' Other Investors

Acuity Pharmaceuticals raised a round of funding on , . Investors include Mitsubishi UFJ Capital.

OPKO Health, Inc. (Amex: OPK) today announced that a study published in the peer-reviewed journal Molecular Vision demonstrates that bevasiranib, its siRNA (small interfering RNA) agent is distributed…

Articles about Acuity Pharmaceuticals' Other Investors: